PCM
INSP icon

Penserra Capital Management’s Inspire Medical Systems INSP Stock Holding History

Penserra Capital Management’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,669
Closed -$3.14M – 1299
2023
Q2 		$3.14M Buy
+9,669
New +$2.76M 0.06% 238
2023
Q1 		– Sell
-10,461
Closed -$2.63M – 1173
2022
Q4 		$2.63M Buy
+10,461
New +$2.23M 0.06% 323
2021
Q4 		– Sell
-5,652
Closed -$1.32M – 1446
2021
Q3 		$1.32M Buy
+5,652
New +$1.18M 0.03% 389

Other funds holding INSP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Penserra Capital Management's INSP Position: Q3 2023 in Review

Penserra Capital Management sold out of Inspire Medical Systems (INSP) in Q3 2023, closing a stake of 9,669 shares — an estimated $3.14M sold.

Penserra Capital Management first reported a position in INSP in Q3 2021 and held it in 3 quarters. The position peaked at $3.14M in Q2 2023. 364 funds tracked by Wall St. Rank hold INSP as of Q3 2023.

  • Penserra Capital Management reported no remaining Inspire Medical Systems position as of Q3 2023 after selling out during the quarter.
  • Penserra Capital Management sold 9,669 Inspire Medical Systems shares in Q3 2023, an estimated $3.14M.
  • Penserra Capital Management first reported a position in Inspire Medical Systems in Q3 2021 and held it in 3 quarters.
  • Penserra Capital Management's Inspire Medical Systems position peaked at $3.14M in Q2 2023.
  • 364 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2023.

Based on Penserra Capital Management's 13F filing for Q3 2023, filed 15 Nov 2023.